Liknaitzky P
Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
PreprintPsychedelics
Contexts, Risks, and Affordances among Autistic Adults Using Psychedelics for Therapeutic Purposes: A Naturalistic, Mixed-Methods Study
ArticlePsilocybin
'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.
PreprintLSD
Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review
PreprintPsilocybin
Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats
ArticlePsilocybin
Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.
PreprintPsilocybin
Psilocybin Experiential Therapist Training: Insights from a World-First Study
ArticlePsilocybin
The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.
ArticlePsilocybin
Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.
PreprintPsilocybin
“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy
ArticlePsilocybin
Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.
ArticlePsychedelics
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey.
ArticlePsychedelics
Insights on psychedelics: A systematic review of therapeutic effects.
ArticlePsilocybin
Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.
ArticlePsilocybin
Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
ArticlePsilocybin
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.
ArticlePsilocybin
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
ArticlePsychedelics
How psychedelic-assisted therapy works for depression: expert views and practical implications from an exploratory Delphi study.
ArticlePsilocybin
Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.
ArticlePsilocybin
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.
ArticlePsilocybin
The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.
ArticlePsilocybin
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
ArticlePsychedelics
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice.
ArticlePsilocybin